ANTIKREBSZUSAMMENSETZUNGEN
Patent europeic · EP3226842 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP3226842
- Numer da la dumonda
- EP15817642
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 03-12-2015
- Publitgà
- 11-10-2017
- Concedì
- 25-11-2020
- La protecziun finescha il pli tard
- 02-12-2035
- Proxima taxa annuala scadenta
- 31-12-2026
- Classas IPC
- A61K 9/14 (2006.01)A61K 9/20 (2006.01)A61P 13/08 (2006.01)A61P 35/00 (2006.01)A61P 35/04 (2006.01)
- Prioritad
- EP 14196591 05.12.2014
- Dumonda PCT
- PCT/US2015/063667 03.12.2015
- Publicaziun PCT
- WO2016/090101 09.06.2016
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-01-2026
Midada
Published in Swissreg on 01.01.2026
- 26-03-2025
Midada
Published in Swissreg on 26.03.2025
- 01-01-2025
Midada
Published in Swissreg on 01.01.2025
- 01-01-2024
Midada
Published in Swissreg on 01.01.2024
- 01-01-2023
Midada
Published in Swissreg on 01.01.2023
- 27-10-2021
Midada
Published in Swissreg on 27.10.2021
- 30-12-2020
Owner
- Owner
- Aragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 301, San Diego, CA 92130, USA → Aragon Pharmaceuticals, Inc., 10990 Wilshire Blvd, Suite 300, Los Angeles, CA 90024, USA
Published in Swissreg on 30.12.2020
- 25-11-2020
Concedì
Published in Swissreg on 25.11.2020
Partidas
Inventur
2340 Beerse, BE
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.